WELLINGTON MANAGEMENT GROUP LLP - G1 THERAPEUTICS INC ownership

G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 109 filers reported holding G1 THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.76 and the average weighting 0.0%.

Quarter-by-quarter ownership
WELLINGTON MANAGEMENT GROUP LLP ownership history of G1 THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$275,600
-51.8%
102,836
-2.4%
0.00%
Q4 2022$572,344
-55.1%
105,404
+3.3%
0.00%
Q3 2022$1,274,000
+213.8%
102,008
+24.1%
0.00%
Q2 2022$406,000
-34.9%
82,2140.0%0.00%
Q1 2022$624,000
-34.3%
82,214
-11.7%
0.00%
Q4 2021$950,000
-95.7%
93,078
-92.5%
0.00%
-100.0%
Q4 2020$22,259,000
-35.5%
1,237,342
-58.6%
0.00%
-42.9%
Q3 2020$34,498,000
-59.0%
2,986,829
-13.9%
0.01%
-63.2%
Q2 2020$84,209,000
+105.4%
3,471,032
-6.7%
0.02%
+72.7%
Q1 2020$40,998,000
-70.0%
3,720,369
-28.0%
0.01%
-62.1%
Q4 2019$136,596,000
+15.6%
5,168,184
-0.4%
0.03%
+7.4%
Q3 2019$118,173,000
-25.6%
5,187,573
+0.1%
0.03%
-22.9%
Q2 2019$158,844,000
+106.4%
5,180,852
+11.7%
0.04%
+105.9%
Q1 2019$76,966,000
+6.6%
4,636,474
+23.0%
0.02%
-5.6%
Q4 2018$72,189,000
-57.0%
3,769,615
+17.5%
0.02%
-48.6%
Q3 2018$167,809,000
+36.5%
3,209,187
+13.5%
0.04%
+29.6%
Q2 2018$122,910,000
+25.8%
2,828,133
+7.2%
0.03%
+22.7%
Q1 2018$97,725,000
+247.8%
2,637,648
+86.2%
0.02%
+266.7%
Q4 2017$28,098,000
+34.1%
1,416,243
+68.2%
0.01%
+20.0%
Q3 2017$20,960,000
+44.0%
842,089
+0.9%
0.01%
+66.7%
Q2 2017$14,555,000834,5630.00%
Other shareholders
G1 THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
MPM BioImpact LLC 1,423,794$34,541,0009.18%
Burrage Capital Management LLC 373,876$9,070,0006.35%
Birchview Capital, LP 40,000$970,0000.59%
361 CAPITAL LLC 47,325$1,148,0000.54%
Rhenman & Partners Asset Management AB 190,000$4,609,0000.50%
CHI Advisors LLC 44,000$1,067,0000.42%
Bellevue Group AG 721,925$17,514,0000.25%
Candriam S.C.A. 870,423$21,117,0000.22%
Virtus ETF Advisers LLC 18,991$461,0000.22%
HHLR ADVISORS, LTD. 949,431$23,033,0000.21%
View complete list of G1 THERAPEUTICS INC shareholders